Published online Dec 6, 2018. doi: 10.12998/wjcc.v6.i15.1036
Peer-review started: August 17, 2018
First decision: October 4, 2018
Revised: November 3, 2018
Accepted: November 7, 2018
Article in press: November 7, 2018
Published online: December 6, 2018
A 19-year-old woman presented with persistent left upper abdominal pain without obvious cause for 1 d. The patient also developed subcutaneous nodules involving lower abdomen bilaterally and lower limbs. An irregular mass was found in the pancreatic body and tail on plain abdominal computed tomography (CT), contrast-enhanced abdominal CT, and contrast-enhanced ultrasound.
Solid pseudopapillary tumor of the pancreas (SPTP), pancreatic panniculitis.
Abnormal laboratory findings included the results of routine blood: Neutrophil-to-lymphocyte ratio 85.5% (normal range: 40%-75%), hemoglobin 88 g/L (normal range: 115-150 g/L). Liver function test showed albumin 30 g/L (normal range: 40-55 g/L) and alanine aminotransferase 62 U/L (normal range: 8-40 U/L). The result of serum amylase was 869 U/L (normal range: 40-100 U/L), and serum lipase was 759 U/L (normal range: 0-110 U/L).
Contrast-enhanced abdominal CT revealed a cystic/solid mass with mixed density in the body and tail of the pancreas.
SPTP, pancreatic panniculitis.
Laparoscopic resection of the mass in the pancreatic body and tail with preservation of the spleen.
Some articles have described the imaging diagnosis and treatment of SPTP and pancreatic panniculitis, as shown in the References.
Clinicians should be aware of the clinical manifestation and treatment of pancreatic panniculitis. Although SPTP has good prognosis and the postoperative 5-year survival rate is high, efforts should be made to increase further diagnostic accuracy and optimize therapeutic methods, so as to improve the quality of life of SPTP patients.